SC 13G

Company

Elicio Therapeutics, Inc.

Filed

April 27, 2022

Accession Number

0001601485-22-000032

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →